Circulating RNA differences between patients with stable and progressive idiopathic pulmonary fibrosis
Eur Respir J
.
2020 Sep 10;56(3):1902058.
doi: 10.1183/13993003.02058-2019.
Print 2020 Sep.
Authors
Britt Clynick
1
2
,
Helen E Jo
3
4
,
Tamera J Corte
3
4
,
Ian N Glaspole
5
6
,
Christopher Grainge
7
8
,
Peter M A Hopkins
9
10
,
Paul N Reynolds
11
12
,
Sally Chapman
12
,
E Haydn Walters
6
13
14
15
,
Christopher Zappala
9
,
Gregory J Keir
9
,
Wendy A Cooper
3
4
16
,
Annabelle M Mahar
3
4
,
Samantha Ellis
6
,
Nicole S Goh
17
18
,
Svetlana Baltic
1
2
,
Marisa Ryan
1
2
,
Dino B A Tan
1
2
,
Yuben P Moodley
1
2
19
Affiliations
1
Institute for Respiratory Health, Nedlands, Australia.
2
University of Western Australia, Crawley, Australia.
3
University of Sydney, Camperdown, Australia.
4
Royal Prince Alfred Hospital, Camperdown, Australia.
5
Monash University, Clayton, Australia.
6
Alfred Hospital, Melbourne, Australia.
7
University of Newcastle, Callaghan, Australia.
8
John Hunter Hospital, New Lambton Heights, Australia.
9
University of Queensland, St Lucia, Australia.
10
Prince Charles Hospital, Chermside, Australia.
11
University of Adelaide, Adelaide, Australia.
12
Royal Adelaide Hospital, Adelaide, Australia.
13
University of Tasmania, Hobart, Australia.
14
University of Melbourne, Parkville, Australia.
15
Royal Hobart Hospital, Hobart, Australia.
16
Western Sydney University, Sydney, Australia.
17
Austin Hospital, Heidelberg, Australia.
18
Institute of Breathing and Sleep, Heidelberg, Australia.
19
Fiona Stanley Hospital, Murdoch, Australia.
PMID:
32381494
DOI:
10.1183/13993003.02058-2019
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Cell-Free Nucleic Acids*
Disease Progression
Humans
Idiopathic Pulmonary Fibrosis* / genetics
Substances
Cell-Free Nucleic Acids